Patents by Inventor Jill Blanchard

Jill Blanchard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic aptamers having binding specificity to gp41 of HIV
    Publication number: 20040137429
    Abstract: Materials and methods of use thereof are presented for the treatment or diagnosis of HIV. The materials are aptamers that bind to gp41, CCR5 or other HIV viral targets that are involved in the formation of the gp41 fusion-active intermediate.
    Type: Application
    Filed: October 1, 2003
    Publication date: July 15, 2004
    Inventors: David Epstein, Jill Blanchard, Charles Wilson, John L. Diener
  • Compositions selective for adenosine diphosphate and methods of using same
    Publication number: 20040018515
    Abstract: Compositions which recognize and report on the concentration selectively adenosine diphosphate (ADP) and methods of making and using them are provided. The invention further relates to methods of using the compositions to monitor function of biological agents. Reagents and systems for performing the methods are also provided. The methods of the invention are useful in diagnostic applications and drug optimization.
    Type: Application
    Filed: April 2, 2003
    Publication date: January 29, 2004
    Inventors: John L. Diener, Jayaram Srinivasan, Nobuko Hamaguchi, Jill Blanchard, Jeffrey Kurz, Markus Kurz, Sharon T. Cload, David Epstein, Charles Wilson, Martin Stanton
  • Method of identifying inhibitors of CDC25
    Publication number: 20020183249
    Abstract: The present invention relates to polypeptides which comprise the ligand binding domain of Cdc25, crystalline forms of these polypeptides and the use of these crystalline forms to determine the three dimensional structure of the catalytic domain of Cdc25. The invention also relates to the use of the three dimensional structure of the Cdc25 catalytic domain in methods of designing and/or identifying potential inhibitors of Cdc25 activity, for example, compounds which inhibit the binding of a native substrate to the Cdc25 catalytic domain.
    Type: Application
    Filed: March 1, 2001
    Publication date: December 5, 2002
    Inventors: Neil R. Taylor, David Borhani, David Epstein, Johannes Rudolph, Kurt Ritter, Taro Fujimori, Simon Robinson, Jens Eckstein, Andreas Haupt, Nigel Walker, Richard W. Dixon, Deborah Choquette, Jill Blanchard, Arthur Kluge, Kollol Pal, Nicholas Bockovich, Jon Come, Mark Hediger